RENEE BARIL: Open Payments
NPI 1053358986 · MANSFIELD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$603 in 29 payments from 9 companies in 2025. Trend: 2023 $347 · 2024 $553 · 2025 $603
Food & beverage: $603
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $172 |
| ABBVIE INC. | 11 | $167 |
| Novo Nordisk Inc | 5 | $95 |
| Janssen Pharmaceuticals, Inc | 3 | $69 |
| Amgen Inc. | 2 | $34 |
| Astellas Pharma US Inc | 1 | $20 |
| Exact Sciences Corporation | 1 | $16 |
| PFIZER INC. | 1 | $15 |
| Rhythm Pharmaceuticals, Inc. | 1 | $14 |
Products named: BREZTRI, QULIPTA, SPRAVATO, Wegovy, AIRSUPRA, VRAYLAR, UBRELVY, Veozah.
Industry payments across TX — which companies pay providers there.
